Patents by Inventor Katalin Juhasz

Katalin Juhasz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10696194
    Abstract: A vehicle seat with fold down child seat includes a passenger seat and a convertible child seat section. In a first seat configuration, the convertible child seat section may be for use by an adult or adolescent. In a second seat configuration, the convertible child seat section may be for use by a child. The convertible child seat section may includes a child seat back that rotates to present a front side for adult seating or a rear side for child seating and a child seat cushion that rotates to present a top side for adult seating or a bottom side for child seating. The seat back and seat cushion may rotate on a seat back spindle and seat bottom cushion, respectively. The convertible child seat section may include a harness. A vehicle seat may comprise multiple convertible child seat sections.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: June 30, 2020
    Inventor: Katalin Juhasz
  • Patent number: 7709007
    Abstract: Attenuated respiratory syncytial virus (RSV) and vaccine compositions thereof are produced by introducing specific mutations associated with attenuating phenotypes into wild-type or RSV which is incompletely attenuated by cold-passage or introduction of mutations which produce virus having a temperature sensitive (ts) or cold adapted (ca) phenotype. Alternatively, recombinant RSV and vaccine compositions thereof incorporate attenuating and other mutations specifying desired structural and or phenotypic characteristics in an infectious RSV. Recombinant RSV incorporate desired mutations specified by insertion, deletion, substitution or rearrangement of a selected nucleotide sequence, gene, or gene segment in an infectious RSV clone. The immune system of an individual is stimulated to induce protection against natural RSV infection, or multivalently against infection by RSV and another pathogen, such as PIV, by administration of attenuated, biologically derived or recombinant RSV.
    Type: Grant
    Filed: September 2, 2004
    Date of Patent: May 4, 2010
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Brian R. Murphy, Peter L. Collins, Stephen S. Whitehead, Alexander A. Bukreyev, Katalin Juhasz, Michael N. Teng
  • Publication number: 20060159703
    Abstract: Attenuated respiratory syncytial virus (RSV) and vaccine compositions thereof are produced by introducing specific mutations associated with attenuating phenotypes into wild-type or RSV which is incompletely attenuated by cold-passage or introduction of mutations which produce virus having a temperature sensitive (ts) or cold adapted (ca) phenotype. Alternatively, recombinant RSV and vaccine compositions thereof incorporate attenuating and other mutations specifying desired structural and or phenotypic characteristics in an infectious RSV. Recombinant RSV incorporate desired mutations specified by insertion, deletion, substitution or rearrangement of a selected nucleotide sequence, gene, or gene segment in an infectious RSV clone. The immune system of an individual is stimulated to induce protection against natural RSV infection, or multivalently against infection by RSV and another pathogen, such as PIV, by administration of attenuated, biologically derived or recombinant RSV.
    Type: Application
    Filed: September 2, 2004
    Publication date: July 20, 2006
    Inventors: Brian Murphy, Peter Collins, Stephen Whitehead, Alexander Bukreyev, Katalin Juhasz, Michael Teng
  • Patent number: 5993824
    Abstract: Attenuated respiratory syncytial virus (RSV) and vaccine compositions thereof are produced by introducing specific mutations associated with attenuating phenotypes into wild-type or RSV which is incompletely attenuated by cold-passage or introduction of mutations which produce virus having a temperature sensitive (ts) or cold adapted (ca) phenotype. Alternatively, recombinant RSV and vaccine compositions thereof incorporate attenuating and other mutations specifying desired structural and or phenotypic characteristics in an infectious RSV. Recombinant RSV incorporate desired mutations specified by insertion, deletion, substitution or rearrangement of a selected nucleotide sequence, gene, or gene segment in an infectious RSV clone. The immune system of an individual is stimulated to induce protection against natural RSV infection, or multivalently against infection by RSV and another pathogen, such as PIV, by administration of attenuated, biologically derived or recombinant RSV.
    Type: Grant
    Filed: July 15, 1997
    Date of Patent: November 30, 1999
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Brian R. Murphy, Peter L. Collins, Stephen S. Whitehead, Alexander A. Bukreyev, Katalin Juhasz, Michael N. Teng